Bernardino Ossola

Dr. Bernardino Ossola

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2022 in Neuropharmacology
Verified
Journal Article
Open access
BOBernardino Ossola
Bernardino Ossola
ARAli Rifat
Ali Rifat
ARAnna Rowland
Anna Rowland
HHHelen Hunter
Helen Hunter
SDSamuel Drinkall
Samuel Drinkall
LDLee A. Dawson
Lee A. Dawson
Neuroinflammation, specifically the NLRP3 inflammasome cascade, is a common underlying pathological feature of many neurodegenerative diseases. Evidence suggests that NLRP3 activation involves changes in intracellular K+. Nuclear Enriched Transcript Sort Sequencing (NETSseq), which allows for deep sequencing of purified cell types from human post-mortem brain tissue, demonstrated a highly specific expression of the tandem pore domain halothane-inhibited K+ channel 1 (THIK-1) in microglia compared to other glial and neuronal cell types in the human brain. NETSseq also showed a significant increase of THIK-1 in microglia isolated from cortical regions of brains with Alzheimer's disease (AD) relative to control donors.

5 April 2024 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RBRoland W. Bürli
Roland W. Bürli
KDKevin J. Doyle
Kevin J. Doyle
LDLouise Dickson
Louise Dickson
ARAnna Rowland
Anna Rowland
KMKim Matthews
Kim Matthews
LDLee A. Dawson
Lee A. Dawson

2 February 2022 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
RBRussell Burley
Russell Burley
RHRichard C. Hewer
Richard C. Hewer
MTMartin Teall
Martin Teall
LDLouise Dickson
Louise Dickson
BOBernardino Ossola
Bernardino Ossola
RBRoland W. Bürli
Roland W. Bürli